AllowayRCanafaxDSchroederT. Bioequivalence of Sang-35 and Neoral for cyclosporine metabolites in stable renal transplant recipients. Transplantation.1998;65:S6.
2.
AllowayRSchroederTRussellW. An open labeled single center bioequivalence comparison of Sandimmune and Neoral versus Sang-35 cyclosporine. Program and abstracts of the 16th Annual Meeting of the American Society of Transplant Physicians; May 10–14, 1997; Chicago, Ill. Abstract 681.
3.
PanSHFisherRALopezR. Comparative pharmacokinetics of Sang-35 cyclosporine versus Neoral in stable adult liver transplant recipients. Transplantation.1998;65:S6.
4.
SchroederTJFirstMRAllowayRRCanafaxDMGaberAOGastonR.A series of comparative trials between Sang-35 and other cyclosporine (CsA) formultations in stable renal transplant patients. Paper presented at the 16th Annual Meeting of the American Society of Transplant Physicians; May 10–14, 1997; Chicago, Ill.
5.
FirstMRAllowayRRSchroederTJ. Development of Sang-35: A cyclosporine formlation beoequivalent to Neoral. Clin Transplant.1998;12:518–524.